Evanston, IL, United States of America

Charles M Baum

This inventor holds 3 USPTO granted patents. Top assignees: G.d. Searle & Company, Pharmacia Corporation. Active years: 2000-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles M Baum. Retrieved from https://idiyas.com/inventor/charles-m-baum-vxsij06z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2000-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Charles M Baum: Innovator in Hematopoietic Receptor Agonist Proteins

Introduction

Charles M Baum is a notable inventor based in Evanston, IL (US), recognized for his contributions to the field of hematopoietic receptor agonist proteins. He holds a total of 3 patents, showcasing his innovative approach to medical science and biotechnology.

Latest Patents

Among his latest patents is the invention titled "Fused G-CSF and IL-3 proteins and uses thereof." This patent discloses novel multi-functional hematopoietic receptor agonist proteins, along with the DNAs that encode these proteins. It also details methods for making and using these multi-functional proteins. Another significant patent is "Thrombopoietin: IL-3 fusion protein," which relates to variants of human c-mpl ligands (thrombopoietin) that have activity on hematopoietic differentiation and expansion.

Career Highlights

Throughout his career, Charles M Baum has worked with prominent companies such as G.D. Searle & Company and Pharmacia Corporation. His work in these organizations has significantly contributed to advancements in biotechnology and pharmaceuticals.

Collaborations

Charles has collaborated with notable individuals in his field, including Nicholas R Staten and John Patrick McKearn. These collaborations have likely enhanced his research and development efforts.

Conclusion

Charles M Baum's innovative work in hematopoietic receptor agonist proteins has made a significant impact in the field of biotechnology. His patents reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…